Rankings
▼
Calendar
DYN
Dyne Therapeutics, Inc.
$3B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$700,000
Operating Income
-$59M
Net Income
-$59M
EPS (Diluted)
$-1.24
Cash Flow
Operating Cash Flow
-$47M
Free Cash Flow
-$48M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$353M
Total Liabilities
$11M
Stockholders' Equity
$342M
Cash & Equivalents
$301M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$700,000
-$271,000
-158.3%
Operating Income
-$59M
-$14M
-324.2%
Net Income
-$59M
-$14M
-333.9%
← Q4 2019
All Quarters
Q1 2020 →
DYN FY 2020 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena